Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial

Chronic migraine is associated with high disability and limited response to existing therapies, particularly in patients experiencing frequent headaches and medication overuse. Noninvasive vagus nerve stimulation (nVNS) has been proposed as a neuromodulatory alternative, but current research has produced inconsistent findings.

A randomized controlled trial by Nasir et. al published in April 2026 aimed to address this gap by evaluating whether a standardized, supervised auricular nVNS protocol could produce short-term improvements in pain, headache severity, and quality of life in adults with chronic migraine.

Design and Intervention
The study enrolled 128 adults meeting ICHD-3 criteria for chronic migraine and randomized them equally into experimental and control groups using concealed allocation. The intervention consisted of transcutaneous auricular stimulation applied at the tragus using a 30 Hz frequency and 200-millisecond pulse width. Sessions were delivered under supervision over four weeks, ensuring full adherence.

The control group received sham stimulation at the earlobe, a site without vagal innervation. Outcome assessors were blinded, although participants were not due to perceptible stimulation.

Pain and Quality-of-Life Outcomes
At baseline, no significant differences were observed between groups. After four weeks, the experimental group showed significantly lower pain intensity on the Numeric Pain Scale, with a mean rank of 36.77 compared with 92.23 in the control group (p<0.001), reflecting a large effect size (r=0.98). Migraine-specific quality of life improved substantially, with mean ranks of 94.59 versus 34.41 (p<0.001; r=0.95). Within-group analysis confirmed significant improvements in both measures only in the intervention arm.

Behavioral and Functional Measures
The multidimensional pain inventory demonstrated a statistically significant between-group difference at four weeks (p=0.035). However, the calculated effect size was small, indicating limited clinical magnitude. Within-group changes showed a modest reduction in the experimental group and negligible change in controls.

These findings suggest that behavioral aspects of pain were less responsive over the short intervention period compared with intensity and quality-of-life measures.

Headache Severity Distribution
Headache diary data showed a marked shift in severity within the experimental group. At four weeks, 50% of episodes were categorized as mild, compared with none at baseline. Moderate and severe episodes decreased accordingly.

In contrast, the control group showed minimal improvement, with severe headaches increasing over time. Triggering and relieving factors did not differ significantly between groups, indicating that observed effects were not attributable to changes in reported triggers.

Limitations and Context
The study relied on patient-reported outcomes without physiological measures of autonomic engagement. The follow-up period was limited to four weeks, restricting conclusions to short-term effects. Single-center design and device constraints may affect generalizability. Participant blinding was not feasible, which may introduce expectation bias.

Clinical Interpretation
This trial demonstrates that supervised auricular nVNS produced significant short-term reductions in pain intensity and improvements in migraine-specific quality of life, with accompanying shifts in headache severity. The magnitude of effect differed across outcomes, with large effects in pain and quality-of-life measures and smaller effects in behavioral indices. These results provide controlled evidence supporting short-term clinical benefit and define a basis for further investigation into durability and mechanism.

Reference:
Nasir R, Baig MO, Abualait T, Obaid S, Jadoon IJ, Al-hussain F, Bashir S. Effects of vagal nerve stimulation on pain frequency and intensity in chronic migraine in adults: a randomized controlled trial. Physiol Rep. 2026;14:e70843. doi:10.14814/phy2.70843